Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1109487

	registered interest
	date	03/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Teenage Pregnancy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the cost to the public purse has been of the teenage pregnancy unit in each year since its creation; and how many civil servants were employed within it in each of those years.
	tabling member constituency	Sheffield, Heeley
	tabling member printed	Louise Haigh
	uin	240592
	answer	answer is ministerial correction date of answer 10/04/2019 answer text <p>The Teenage Pregnancy Unit was established to drive delivery of national work to reduce under 18 conceptions by 2010. Details of staff numbers and the costs involved are no longer held. Since 2010 this work has been devolved to local authorities. Between 2010 and 2016, the latest year for which data is available, under 18 conceptions fell by 45%.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/04/2019 10:37:34 answering member 4455 label Biography information for Seema Kennedy previous answer version 112580 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
	tabling member	4473 label Biography information for Louise Haigh

1110964

	registered interest
	date	10/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Crohn's Disease
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the change in the number of people diagnosed with Crohn's disease between 2008 and 2018.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	243360
	answer	answer is ministerial correction date of answer 17/04/2019 answer text <p>Information regarding number of patients diagnosed with Crohn’s disease in any one year is not available, and therefore no estimate has been made. The National Institute for Health and Care Excellence guidance, ‘Crohn’s disease: management’, updated in 2016 to reflect the last available evidence, states that at least 115,000 people in the United Kingdom have the condition.</p><p> </p><p>The guidance can be found at the following link:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085" target="_blank">www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085</a></p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/04/2019 12:04:18 answering member 4455 label Biography information for Seema Kennedy previous answer version 114109 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
	tabling member	1409 label Biography information for Mr Gregory Campbell

1111101

	registered interest
	date	10/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent estimate his Department has made of the number of NHS prescriptions for medicine in which THC is the dominant ingredient.
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	uin	243361
	answer	answer is ministerial correction date of answer 17/04/2019 answer text <p>The Department has made no estimate of the number of National Health Service prescriptions for cannabis-based products in which delta-9-tetrahydrocannabinol (THC) is the dominant ingredient.</p><p> </p><p>NHS England is using extant systems to monitor use of the newly rescheduled unlicensed cannabis-based products for medicinal use in England. In England, these systems monitor the number of items dispensed and associated costs in primary care and the volume of products used and associated cost in secondary care. NHS England Controlled Drug Accountable Officers are also collecting local intelligence in both the NHS and independent sector.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/04/2019 11:49:19 answering member 4455 label Biography information for Seema Kennedy previous answer version 114110 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
	tabling member	1436 label Biography information for Paul Farrelly

1123445

	registered interest
	date	26/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Infant Foods
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will publish the (a) dates, (b) attendees and (c) topics of meetings his Department has had with representatives of the formula milk industry in 2018 and 2019 to date.
	tabling member constituency	Washington and Sunderland West
	tabling member printed	Mrs Sharon Hodgson
	uin	247997
	answer	answer is ministerial correction date of answer 07/05/2019 answer text <p>The Department has provided details of meetings between Departmental officials with representatives of the formula milk industry. Meetings organised by executive agencies or the Food Standards Agency have not been included. We have not disclosed details of staff attending as they were not Senior Civil Service grade. The information is shown in the following table.</p><table><tbody><tr><td><p>Date</p></td><td><p>Organisation</p></td><td><p>Discussion</p></td></tr><tr><td><p>26 February 2018</p></td><td><p>Nestle</p></td><td><p>Presentation on action on sustainable diets</p></td></tr><tr><td><p>26 March 2018</p></td><td><p>Nestle</p></td><td><p>Phone call</p></td></tr><tr><td><p>25 April 2018</p></td><td><p>Danone and Nutrica</p></td><td><p>Early Years Nutrition Partnership</p></td></tr><tr><td><p>6 June 2018</p></td><td><p>British Specialist Nutrition Association (BSNA), Nestle, Nutrica</p></td><td><p>Notifications for Foods for Special Medical Purposes</p></td></tr><tr><td><p>22 June 2018</p></td><td><p>Nestle</p></td><td><p>Planning for visit</p></td></tr><tr><td><p>4 July 2018</p></td><td><p>Nestle</p></td><td><p>Visit</p></td></tr><tr><td><p>11 July 2018</p></td><td><p>Danone</p></td><td><p>Aptamil</p></td></tr><tr><td><p>30 July 2018</p></td><td><p>Danone</p></td><td><p>Childhood Obesity Chapter 2</p></td></tr><tr><td><p>14 August 2018</p></td><td><p>Nestle</p></td><td><p>Childhood Obesity Chapter 2</p></td></tr><tr><td><p>22 August 2018</p></td><td><p>BSNA</p></td><td><p>Phone meeting</p></td></tr><tr><td><p>10 September 2018</p></td><td><p>Danone and Nestle</p></td><td><p>Advertising roundtable</p></td></tr><tr><td><p>14 November 2018</p></td><td><p>BSNA</p></td><td><p>Nutrition legislation meeting</p></td></tr><tr><td><p>15 November 201<ins class="ministerial">8</ins><del class="ministerial">9</del></p></td><td><p>Danone</p></td><td><p>Reformulation, Brexit pressure, and Chapter</p></td></tr><tr><td><p>22 November 201<ins class="ministerial">8</ins><del class="ministerial">9</del></p></td><td><p>BSNA</p></td><td><p>Forthcoming CODEX CCNFSDU40</p></td></tr></tbody></table><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 07/05/2019 16:50:53 question first ministerially corrected 14/05/2019 10:58:49 answering member 4455 label Biography information for Seema Kennedy previous answer version 116720 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
	tabling member	1521 label Biography information for Mrs Sharon Hodgson

1128442

	registered interest
	date	23/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will publish the evidence (a) his Department and (b) the Department for International Trade holds on growing a market for prescribed medicinal cannabis.
	tabling member constituency	Hemel Hempstead
	tabling member printed	Sir Mike Penning
	uin	257706
	answer	answer is ministerial correction date of answer 10/06/2019 answer text <p><ins class="ministerial"> <p><ins class="ministerial">The Department for International Trade and the Department of Health and Social Care are not specifically collecting data on the growth of the market for cannabis based products for medicinal use in the United Kingdom.</ins></p><p><ins class="ministerial">However, data from the Medicines and Healthcare products Regulatory Agency (MHRA) shows growing numbers of import notifications for medicinal cannabis and the Home Office has received increased numbers of licence applications.</ins></p><p><ins class="ministerial">In addition, UK companies exporting these products and foreign companies looking to invest in the UK have full access to government support, where they have the necessary authorisations from the MHRA and Home Office and a relevant Export Licence.</ins></p></ins></p><p><del class="ministerial">An initial impact assessment was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. This can be viewed at the following link:</del></p><p><del class="ministerial"><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></del></p><p><del class="ministerial">This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of cannabis-based products for medicinal use (CBPM). This framework included potential savings in treatment costs, giving the example of patients with severe epilepsy for whom medicinal use of cannabis could reduce the frequency of seizures and reduce the number of related hospital admissions. This was an initial framework for assessing this policy and as we develop our knowledge in this area, both on the costs and the potential benefits, we can revisit and refine these assessments.</del></p><p><del class="ministerial">In the meantime, the National Institute for Health and Care Excellence (NICE) is developing clinical guidelines on the appropriate use of CBPM based on the best available evidence, and the National Institute for Health Research is funding further clinical research on this. More information is available at the following link:</del></p><p><del class="ministerial"><a href="https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf" target="_blank">https://www.nihr.ac.uk/funding-and-support/documents/themed-calls/cannabis-based%20products/cannabis-based-products-brief.pdf</a></del></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/06/2019 13:18:03 question first ministerially corrected 11/06/2019 11:31:21 answering member 4455 label Biography information for Seema Kennedy previous answer version 121340 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
	tabling member	1528 label Biography information for Sir Mike Penning

1129191

	registered interest
	date	03/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many prescriptions of (a) individual benzodiazepine drugs and (b) individual antidepressants were dispensed in the community in 2018.
	tabling member constituency	Bristol North West
	tabling member printed	Darren Jones
	uin	259400
	answer	answer is ministerial correction date of answer 11/06/2019 answer text <p>Information on the number of prescription items from the Prescription Cost Analysis system for benzodiazepines and antidepressants written in the United Kingdom and dispensed in the community in England, for the year 2018 can be found in the attached tables.</p><p>The data available is at prescription item level by presentation. Prescriptions are prescribed either by a paper prescription form or via an Electronic Prescription Service message. Each single item written on the form is counted as a prescription item. No information is available for those prescriptions written but not dispensed.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 11/06/2019 16:51:00 question first ministerially corrected 12/06/2019 14:34:05 answering member 4455 label Biography information for Seema Kennedy attachment 1 file name PQ259400 table formatted.docx title Prescription data benzodiazipines & antidepressant previous answer version 122124 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
	tabling member	4621 label Biography information for Darren Jones

1132035

	registered interest
	date	13/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Primary Care Networks
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the requirements for primary care networks to engage with the local community will be.
	tabling member constituency	Newton Abbot
	tabling member printed	Anne Marie Morris
	uin	264406
	answer	answer is ministerial correction date of answer 18/06/2019 answer text <p><ins class="ministerial"> <p><ins class="ministerial">Primary Care Networks (PCNs) are a new way for primary and community service organisations to work together. For PCNs to be successful they will need to work in partnership with local people and the communities they serve. Legal duties which currently apply to NHS service providers - including general practitioner practices - and commissioners around engagement and consultation will continue to be valid for PCNs.</ins></p></ins></p><p><del class="ministerial">NHS England and NHS Improvement, together with the National Institute for Health and Care Excellence, is developing a ’commercial framework’ setting out the parameters for the commercial approach for medicines in the health service in England.</del></p><p><del class="ministerial">The commercial framework will support a single, transparent, robust and integrated pricing and market access process, and is being tested with and informed through consultation with stakeholders including the Association of the British Pharmaceutical Industry.</del></p><p><del class="ministerial">In preparation for public consultation in the coming months, NHS England is actively engaging with industry trade bodies and health system partners, in the first instance, to outline progress on the development of the commercial framework. The consultation on the draft framework is anticipated to be launched in Quarter 3 2019 with consultation events to be held in Manchester and London, and implementation of the commercial framework is expected to follow.</del></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 18/06/2019 16:34:05 question first ministerially corrected 19/06/2019 08:36:30 answering member 4455 label Biography information for Seema Kennedy previous answer version 123829 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
	tabling member	4249 label Biography information for Anne Marie Morris

1132104

	registered interest
	date	13/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	MMR Vaccine
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the correlation between falling rates of vaccination for measles, mumps and rubella and the increased incidence of those conditions.
	tabling member constituency	Wolverhampton North East
	tabling member printed	Emma Reynolds
	uin	264387
	answer	answer is ministerial correction date of answer 24/06/2019 answer text <p>There has been an increase in cases of measles since the end of 2017 with close to 1,000 cases reported in 2018. However, the majority of these cases (628/966, 65%) are in individuals aged less than one year old and over 15 years i.e. those not in recently vaccinated age cohorts. Data is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/measles-mumps-and-rubella-laboratory-confirmed-cases-in-england-2018" target="_blank">https://www.gov.uk/government/publications/measles-mumps-and-rubella-laboratory-confirmed-cases-in-england-2018</a></p><p>An increase in mumps activity was observed in England in the first quarter (Q1) of 2019 with 795 laboratory confirmed mumps infections. Almost half (352/795, 44%) of the cases in Q1 were in unvaccinated individuals. This data can be viewed at the following link:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/804024/hpr1819_mmr2.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/804024/hpr1819_mmr2.pdf</a></p><p>The World Health Organization confirmed that the United Kingdom had eliminated rubella in 2015. Between 2013-18 there were only 10 laboratory confirmed cases in England. This data can be viewed at the following link:</p><p><a href="https://www.gov.uk/government/publications/rubella-confirmed-cases/rubella-notifications-and-confirmed-cases-by-oral-fluid-testing-in-england-2013-to-2014-by-quarter" target="_blank">https://www.gov.uk/government/publications/rubella-confirmed-cases/rubella-notifications-and-confirmed-cases-by-oral-fluid-testing-in-england-2013-to-2014-by-quarter</a></p><p>Nearly all these cases have been in individuals born abroad and were not eligible to receive rubella containing vaccine in United Kingdom.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 24/06/2019 16:57:13 answering member 4455 label Biography information for Seema Kennedy previous answer version 123818 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
	tabling member	4077 label Biography information for Emma Reynolds

1136975

	registered interest
	date	04/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Members: Correspondence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when his Department plans to respond to the correspondence of 28 May 2019 from the hon. Member for Glasgow Central to the Under-Secretary of State for Mental Health, Inequalities and Suicide Prevention on food for special medical purposes.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	273407
	answer	answer is ministerial correction date of answer 10/07/2019 answer text <p>We are sorry for the delay in responding to the hon. Member’s letter of 28 May. A response will be issued shortly.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 10/07/2019 16:21:41 answering member 4455 label Biography information for Seema Kennedy previous answer version 128076 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
	tabling member	4430 label Biography information for Alison Thewliss

1138808

	registered interest
	date	15/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Addictions: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 8 July 2019 to Question 270772 on Addiction Services, what assessment he has made of the adequacy of the number of medically-staffed inpatient detoxification beds in England; and if he will make a statement.
	tabling member constituency	Central Suffolk and North Ipswich
	tabling member printed	Dr Dan Poulter
	uin	277157
	answer	answer is ministerial correction date of answer 19/07/2019 answer text <p>No national assessment has been made of the adequacy of the number of medically-staffed inpatient detoxification beds in England. Local authorities are responsible for assessing local substance misuse need, and commissioning services to meet that need, including inpatient medically-staffed detoxification beds in England.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 19/07/2019 09:46:52 answering member 4455 label Biography information for Seema Kennedy previous answer version 129854 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
	tabling member	3932 label Biography information for Dr Dan Poulter